Cross SyndromeNCT06739889
Effects of ELAVl and CDOA vs Upper Thoracic Mobilization on Forward Head Posture in Upper Cross Syndrome
A study testing Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA and upper thoracic mobilization in people with Cross Syndrome, run by Superior University at 1 site in Pakistan.
Trial summary
This randomized controlled study will examine the patient of forward head posture who suffering with upper cross syndrome. There will be comparison of two treatment methods 1st one is elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA and 2nd is upper thoracic… Read more about this study
- Who is it for?
- Ages 20 to 45 years
- Conditions the study is for
- Cross Syndrome
- What is being tested?
- Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA and upper thoracic mobilization
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Mar 2024to 28 Feb 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Adult between (20 to 45 year) with upper cross syndrome
- CVA angle less than 48-50 degrees.
- No history of spinal injury and fracture
- limited cervical range of motion
Who cannot join
- Severe spinal degeneration or deformity
- Injury or surgery
- Cervical radiculopathy
- Severe osteoporosis
- Malignancy of upper extremity of thorax
- Obesity
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Elongation Longitudinaux Articular Vertebral and Columnar Decoaption Osteo-articulaire Versus Upper Thoracic Mobilization on Forward Head Posture in Upper Cross Syndrome
This randomized controlled study will examine the patient of forward head posture who suffering with upper cross syndrome. There will be comparison of two treatment methods 1st one is elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA and 2nd is upper thoracic mobilization .
Read the detailed description
This study includes 42 participants, both male and female, age between 20 to 45. ELDOA target the cervical and upper thoracic spine to improve range of motion, restore normal cervical and thoracic spine alignment and reduce muscle tension. Upper thoracic mobilization improve thoracic spine mobility and enhance cervical spine alignment.
- Conditions
- Cross Syndrome
- Being tested
- Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA, upper thoracic mobilization
- Medical subject headings
- Oculocerebral hypopigmentation syndrome type Preus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOADiagnostic test
ELDOA targtes cervical and upper thoracic spine. ELDOA exercises involves spicific postural holds that improve forward neck posture.The goal of ELDOA is to help reduce stress and increase space in the vertebral joints so that muscles can move freely. The benefits of these stretches include joint mobility, increased fluid absorption in the discs of the spine, flexibility, improved muscle tone, postural alignment, body-mind connection, and coordination. The tension and release created by these stretches helps normalize the posture.
upper thoracic mobilizationDiagnostic test
Upper thoracic mobilization, often known as joint mobilization, is a common technique in manual therapy. In order to preserve or restore joint mobility, this approach glides and uses distraction on the joint surfaces.
| Study group | Role | What they receive |
|---|---|---|
| Interventional group I | Experimental | Not described Receives: Diagnostic Test: Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA |
| Interventional group II | Active comparator | Not described Receives: Diagnostic Test: upper thoracic mobilization |
What is being measured
The primary outcome is the main question the study is designed to answer.
Tragus to wall test
Tragus to wall test for forward head posture assessment: normal below 10 centimetres , 10.1- 12 centimetres for mild positive forward head posture,12.1-15 centimetres moderate forward head posture, less than 15 centimetres severe forward head posture.
Measured: 12 Months
Craniovertebral angle assess
Craniovertebral angle assess by web plot digitizer software: normal CVA value 48-50 degree, positive forward head posture less than 48 degree
Measured: 12 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Dec 2024
- Study start1 Mar 2024
- Primary completion1 Sep 2024
- Study completion28 Feb 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cross SyndromeStudies of the same condition, open and under way.
- More trials run by Superior UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Superior University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muhammad Naveed Babur, Superior University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06739889
- Sponsor's protocol ID
- MSRSW/Batch-Fall22/767
- Status last verified
- Dec 2024
- First submitted
- 13 Dec 2024
- Last updated
- 18 Dec 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Elongation Longitudinaux Articular Vertebral and Columnar Decoaption Osteo-articulaire Versus Upper Thoracic Mobilization on Forward Head Posture in Upper Cross Syndrome
- ClinicalTrials.gov ID
- NCT06739889
- Acronym / sponsor ID
- MSRSW/Batch-Fall22/767
- Conditions
- Cross Syndrome
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 42 participants (actual)
- Lead sponsor
- Superior UniversityUniversity, hospital or other
- Study start
- 1 Mar 2024 (actual)
- Primary completion
- 1 Sep 2024 (actual)
- Study completion
- 28 Feb 2025 (estimated)
- First posted
- 18 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled study will examine the patient of forward head posture who suffering with upper cross syndrome. There will be comparison of two treatment methods 1st one is elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA and 2nd is upper thoracic mobilization .
Detailed description
This study includes 42 participants, both male and female, age between 20 to 45. ELDOA target the cervical and upper thoracic spine to improve range of motion, restore normal cervical and thoracic spine alignment and reduce muscle tension. Upper thoracic mobilization improve thoracic spine mobility and enhance cervical spine alignment.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Interventional group I | Experimental | Diagnostic Test: Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA |
| Interventional group II | Active comparator | Diagnostic Test: upper thoracic mobilization |
Who may qualify
- Ages
- 20 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Adult between (20 to 45 year) with upper cross syndrome
- CVA angle less than 48-50 degrees.
- No history of spinal injury and fracture
- limited cervical range of motion
Key exclusion criteria (6 listed)
- Severe spinal degeneration or deformity
- Injury or surgery
- Cervical radiculopathy
- Severe osteoporosis
- Malignancy of upper extremity of thorax
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOAELDOA targtes cervical and upper thoracic spine. ELDOA exercises involves spicific postural holds that improve forward neck posture.The goal of ELDOA is to help reduce stress and increase space in the vertebral joints so that muscles can move freely. The benefits of these stretches include joint mobility, increased fluid absorption in the discs of the spine, flexibility, improved muscle tone, postural alignment, body-mind connection, and coordination. The tension and release created by these stretches helps normalize the posture. | Diagnostic test | Interventional group I |
| upper thoracic mobilizationUpper thoracic mobilization, often known as joint mobilization, is a common technique in manual therapy. In order to preserve or restore joint mobility, this approach glides and uses distraction on the joint surfaces. | Diagnostic test | Interventional group II |
Primary outcome
Tragus to wall test
Time frame: 12 Months
Tragus to wall test for forward head posture assessment: normal below 10 centimetres , 10.1- 12 centimetres for mild positive forward head posture,12.1-15 centimetres moderate forward head posture, less than 15 centimetres severe forward head posture.
Craniovertebral angle assess
Time frame: 12 Months
Craniovertebral angle assess by web plot digitizer software: normal CVA value 48-50 degree, positive forward head posture less than 48 degree
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Dec 2024.
- Individual participant dataSharing planned: No
Related trials for Cross Syndrome
Not yet recruitingObservational study
"Comparison of Oxygen Reserve Index (ORI), End-Tidal Oxygen, and Time-Based Preoxygenation Targets With Arterial Blood Gas During Preoxygenation
Preoxygenation Adequacy Assessed by Oxygen Reserve Index, End-tidal Oxygen and Arterial Blood Gas
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Not yet recruitingObservational study
Postural Control and Balance Performance in Patients With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Postural Assessment
RecruitingPhase 1
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Asthma, Mild Asthma
Active, not recruiting
SweetSpot - The Effect of Non-nutritive Sweeteners on Health
Healthy Adult
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA and upper thoracic mobilization in people with Cross Syndrome, run by Superior University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 18 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Tragus to wall test (time frame: 12 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2024.